Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Survey: Most physicians who treat STIs in their offices lack key injectable drugs

Publish date:: October 17, 2019

Key clinical point: Physicians who treat STIs in their offices should maintain stocks of the appropriate injectable drugs.

Major finding: Among physicians treating STIs in their offices, 77.9% did not have penicillin G benzathine available on- site, and 56.1% did not have ceftriaxone.

Study details: Survey results from the 2016 Physician Induction File of the National Ambulatory Medical Care Survey.

Disclosures: The authors are all employees of the CDC and did not provide other disclosures.

Citation:

Pearson WS et al. Emerg Infect Dis. 2019. doi: 10.3201/eid2511.190764.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Infectious Diseases

Obesity, hypoxia predict severity in children with COVID-19,

Prophylactic HIV treatment in female STI patients is rare,

Combo DAA treatments may benefit patients with resistant HCV genotype 3,

Pronounced racial differences in HBsAg loss after stopping nucleos(t)ide,

Opt-out policy at a syringe service program increased HIV/HCV testing,